Akebia Therapeutics Files 2024 10-K
Ticker: AKBA · Form: 10-K · Filed: Mar 13, 2025 · CIK: 1517022
| Field | Detail |
|---|---|
| Company | Akebia Therapeutics, Inc. (AKBA) |
| Form Type | 10-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
Related Tickers: AKBA
TL;DR
Akebia's 2024 10-K is in! Full financial picture for the year ending Dec 31, 2024, now available.
AI Summary
Akebia Therapeutics, Inc. filed its 2024 10-K on March 13, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Cambridge, MA, operates in the pharmaceutical preparations sector. Key financial data and operational details for 2024 and prior periods are included in this annual report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Akebia's financial performance, business operations, and risks for the fiscal year 2024, enabling informed investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Akebia faces inherent risks related to drug development, regulatory approvals, market competition, and intellectual property.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Prior Fiscal Year (For comparative financial analysis)
- 123 — Public Document Count (Indicates the volume of documents associated with the filing)
Key Players & Entities
- Akebia Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-13 (date) — Filing date
- Cambridge, MA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What was Akebia Therapeutics' total revenue for the fiscal year ended December 31, 2024?
The filing indicates revenue data for the fiscal year 2024, but specific total revenue figures are not provided in this header information.
What is the company's primary business segment?
Akebia Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted on March 13, 2025.
What is the company's state of incorporation?
Akebia Therapeutics, Inc. is incorporated in Delaware (DE).
What are the key dates covered by this filing?
The filing covers the fiscal year ending December 31, 2024, and includes comparative data for previous periods such as December 31, 2023, and December 31, 2022.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 13, 2025 regarding Akebia Therapeutics, Inc. (AKBA).